PortfoliosLab logoPortfoliosLab logo
NEXT vs. BSX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

NEXT vs. BSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in NextDecade Corporation (NEXT) and Boston Scientific Corporation (BSX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NEXT achieves a 27.51% return, which is significantly higher than BSX's -50.99% return. Over the past 10 years, NEXT has underperformed BSX with an annualized return of -3.97%, while BSX has yielded a comparatively higher 6.81% annualized return.


NEXT

1D
-0.15%
1M
-11.35%
6M
27.03%
YTD
27.51%
1Y
-39.46%
3Y*
6.91%
5Y*
15.35%
10Y*
-3.97%
ALL TIME*
-3.33%

BSX

1D
1.59%
1M
3.52%
6M
-50.04%
YTD
-50.99%
1Y
-55.67%
3Y*
-3.43%
5Y*
0.49%
10Y*
6.81%
ALL TIME*
7.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.03B$866.01M$1.00B
$23.47M$19.82M$23.11M

NEXT vs. BSX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
NEXT
NextDecade Corporation
27.51%-31.65%61.64%-3.44%73.33%36.36%-65.96%13.70%-35.10%-17.79%
BSX
Boston Scientific Corporation
-50.99%6.75%54.51%24.94%8.92%18.16%-20.50%27.96%42.56%14.61%

Correlation

The correlation between NEXT and BSX is -0.07, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.07

Correlation (3Y)
Balances recent behavior with more history.

0.08

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.15

Correlation (10Y)
Provides a long-term view across more market conditions.

0.16

Correlation (All Time)
Calculated using the full available price history since Jun 4, 2015

0.14

The correlation between NEXT and BSX shifts across timeframes, from -0.07 (1 year) to 0.16 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

NEXT:

$1.78B

BSX:

$69.46B

EPS

NEXT:

-$1.36

BSX:

$2.38

Total Revenue (TTM)

NEXT:

$0.00

BSX:

$20.62B

Gross Profit (TTM)

NEXT:

-$9.03M

BSX:

$14.52B

EBITDA (TTM)

NEXT:

-$350.02M

BSX:

$4.76B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NEXT vs. BSX — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

NEXT
NEXT Risk / Return Rank: 1818
Overall Rank
NEXT Sharpe Ratio Rank: 1616
Sharpe Ratio Rank
NEXT Sortino Ratio Rank: 1818
Sortino Ratio Rank
NEXT Omega Ratio Rank: 1919
Omega Ratio Rank
NEXT Calmar Ratio Rank: 1717
Calmar Ratio Rank
NEXT Martin Ratio Rank: 2222
Martin Ratio Rank

BSX
BSX Risk / Return Rank: 33
Overall Rank
BSX Sharpe Ratio Rank: 00
Sharpe Ratio Rank
BSX Sortino Ratio Rank: 11
Sortino Ratio Rank
BSX Omega Ratio Rank: 11
Omega Ratio Rank
BSX Calmar Ratio Rank: 77
Calmar Ratio Rank
BSX Martin Ratio Rank: 33
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

NEXT vs. BSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for NextDecade Corporation (NEXT) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NEXTBSXDifference
Sharpe ratioReturn per unit of total volatility

+0.92

Sortino ratioReturn per unit of downside risk

+1.76

Omega ratioGain probability vs. loss probability

0.92

0.66

+0.26

Calmar ratioReturn relative to maximum drawdown

-0.72

-0.92

+0.20

Martin ratioReturn relative to average drawdown

-1.03

-1.64

+0.61

NEXT vs. BSX - Sharpe Ratio Comparison

The current NEXT Sharpe Ratio is -0.63, which is higher than the BSX Sharpe Ratio of -1.55. The chart below compares the historical Sharpe Ratios of NEXT and BSX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

NEXT vs. BSX - Drawdown Comparison

The maximum NEXT drawdown since its inception was -88.79%, roughly equal to the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for NEXT and BSX.


Loading charts...

Drawdown Indicators


NEXTBSXDifference

Max Drawdown

Largest peak-to-trough decline

-88.79%

-89.15%

+0.36%

Max Drawdown (1Y)

Largest decline over 1 year

-57.14%

-60.58%

+3.44%

Max Drawdown (3Y)

Largest decline over 3 years

-60.00%

-60.58%

+0.58%

Max Drawdown (5Y)

Largest decline over 5 years

-60.00%

-60.58%

+0.58%

Max Drawdown (10Y)

Largest decline over 10 years

-88.79%

-60.58%

-28.21%

Current Drawdown

Current decline from peak

-44.00%

-56.79%

+12.79%

Average Drawdown

Average peak-to-trough decline

-39.00%

-38.83%

-0.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

40.41%

33.75%

+6.66%

Volatility

NEXT vs. BSX - Volatility Comparison

NextDecade Corporation (NEXT) has a higher volatility of 21.35% compared to Boston Scientific Corporation (BSX) at 9.18%. This indicates that NEXT's price experiences larger fluctuations and is considered to be riskier than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


NEXTBSXDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.35%

9.18%

+12.17%

Volatility (6M)

Calculated over the trailing 6-month period

49.09%

33.80%

+15.29%

Volatility (1Y)

Calculated over the trailing 1-year period

64.56%

35.80%

+28.76%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

75.98%

25.98%

+50.00%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

87.46%

27.43%

+60.03%

Dividends

NEXT vs. BSX - Dividend Comparison

Neither NEXT nor BSX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

NEXT vs. BSX - Financials Comparison

This section allows you to compare key financial metrics between NextDecade Corporation and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


NEXT and BSX have a correlation of -0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NEXT has higher volatility (21.35%) compared to BSX (9.18%). In terms of maximum drawdown, NEXT dropped -88.79% vs BSX's -89.15%.

NEXT currently has the higher Sharpe Ratio (-0.63 vs -1.55), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for NEXT and BSX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer